UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective

Biomedicines, 2023-02, Vol.11 (2), p.510

2023

Volltextzugriff (PDF)

Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1217495-1217495

2024

Volltextzugriff (PDF)

Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy

Prague medical report, 2022, Vol.123 (1), p.35-42

2022

Volltextzugriff (PDF)

Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography (cT) and Pathology (pT) in a Multicenter Series of Breast Metaplastic Carcinoma Patients

Cancers, 2023-12, Vol.16 (1), p.188

2023

Volltextzugriff (PDF)

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population

Cancers, 2022-07, Vol.14 (14), p.3353

2022

Volltextzugriff (PDF)

First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Results from KEYNOTE-427 cohort B

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.546-546

2019

Volltextzugriff (PDF)

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience

Biomedicines, 2022-10, Vol.10 (10), p.2528

2022

Volltextzugriff (PDF)

Low frequency of HPV positivity in breast tumors among patients from south-central Poland

Infectious agents and cancer, 2021-11, Vol.16 (1), p.1-67, Article 67

2021

Volltextzugriff (PDF)

Primary cardiac atrial sarcomas. Report of two histologically different cases and review of the literature

Polish journal of pathology, 2021, Vol.72 (4), p.358-369

2021

Volltextzugriff (PDF)

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1029-1039

2021

Volltextzugriff (PDF)

High CA 19.9 concentration as an diagnostic dilemma in gastrointestinal cancer survivors

Nowotwory, 2024-06

2024

Volltextzugriff (PDF)

Relationship of adverse events after combined immunotherapy and treatment outcomes in patients with advanced melanoma: A multicenter experience in Poland

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21511-e21511

2023

Volltextzugriff (PDF)

Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study

Journal of gynecologic oncology, 2025, Vol.36

2025

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study

Acta oncologica, 2024-08, Vol.63, p.620-635

2024

Volltextzugriff (PDF)

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

Journal of cancer research and clinical oncology, 2014-12, Vol.140 (12), p.2009-2019

2014

Volltextzugriff (PDF)

Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion – An experience of a cancer reference centre in Poland

European journal of cancer (1990), 2023-01, Vol.178, p.234-242

2023

Volltextzugriff (PDF)

QTc prolongations as a result of drug interactions of CD4/6 inhibitors

Nowotwory, 2022-08, Vol.72 (4), p.258-258

2022

Volltextzugriff (PDF)

Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography in a Multicenter Series of Breast Metaplastic Carcinoma Patients

Cancers, 2023-12, Vol.16 (1)

2023

Volltextzugriff (PDF)

Deeskalacja terapii systemowej zaawansowanego raka jelita grubego – uzasadniona praktyka kliniczna w aspekcie skuteczności i bezpieczeństwa

Nowotwory, 2021-10, Vol.71 (5), p.303-310

2021

Volltextzugriff (PDF)

Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis

Oncology and therapy, 2024-06

2024

Volltextzugriff (PDF)

Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group

Pathology oncology research, 2012-10, Vol.18 (4), p.949-960

2012

Volltextzugriff (PDF)

First-line pembrolizumab (pembro) monotherapy in advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5034-5034

2020

Volltextzugriff (PDF)

KEYNOTE-427 cohort B: First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (NCC-RCC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4569-4569

2019

Volltextzugriff (PDF)

Adjuvant combined therapy with trastuzumab in patients with HER2‑ positive breast cancer and cardiac alterations: implications for optimal cardio‑oncology care

Polskie archiwum medycyny wewne̦trznej, 2022-04, Vol.132 (4)

2022

Volltextzugriff (PDF)

The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings

Tumor biology, 2016-06, Vol.37 (6), p.7645-7655

2016

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(54)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective

Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity

Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy

Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography (cT) and Pathology (pT) in a Multicenter Series of Breast Metaplastic Carcinoma Patients

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population

First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Results from KEYNOTE-427 cohort B

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience

Low frequency of HPV positivity in breast tumors among patients from south-central Poland

Primary cardiac atrial sarcomas. Report of two histologically different cases and review of the literature

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

High CA 19.9 concentration as an diagnostic dilemma in gastrointestinal cancer survivors

Relationship of adverse events after combined immunotherapy and treatment outcomes in patients with advanced melanoma: A multicenter experience in Poland

Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study

Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion – An experience of a cancer reference centre in Poland

QTc prolongations as a result of drug interactions of CD4/6 inhibitors

Discrepancy between Tumor Size Assessed by Full-Field Digital Mammography or Ultrasonography in a Multicenter Series of Breast Metaplastic Carcinoma Patients

Deeskalacja terapii systemowej zaawansowanego raka jelita grubego – uzasadniona praktyka kliniczna w aspekcie skuteczności i bezpieczeństwa

Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis

Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group

First-line pembrolizumab (pembro) monotherapy in advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B

KEYNOTE-427 cohort B: First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (NCC-RCC)

Adjuvant combined therapy with trastuzumab in patients with HER2‑ positive breast cancer and cardiac alterations: implications for optimal cardio‑oncology care

The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings

Suchergebnisse filtern